Clinical Trial Update: A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV [Phase 2]

View source ↗

Summary

Phase II double-blind study evaluating two doses of SC-49483 in combination with Zidovudine (ZDV) versus ZDV alone in HIV infections; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• SC-49483
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED